1308eP Efficacy of isatuximab plus dexamethasone versus non isatuximab-based treatments in refractory multiple myeloma: A systematic review and meta-analysis

Simple item page
dc.contributor.authorVíctor Castillo
dc.contributor.authorLuis E. Cueva-Cañola
dc.contributor.authorAlex Torres
dc.contributor.authorA. Pérez
dc.contributor.authorAlejandro Campos-Muñoz
dc.contributor.authorAbraham Zenteno-Aguilar
dc.contributor.authorKaroly Pamela Zuñiga Montaño
dc.contributor.authorSergio Morales Acosta
dc.contributor.authorWagner Rios-García
dc.contributor.authorCarlos Eduardo Espinosa Temaxte
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T21:06:29Z
dc.date.available2026-03-22T21:06:29Z
dc.date.issued2025
dc.identifier.doi10.1016/j.annonc.2025.08.1942
dc.identifier.urihttps://doi.org/10.1016/j.annonc.2025.08.1942
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/85974
dc.language.isoen
dc.publisherElsevier BV
dc.relation.ispartofAnnals of Oncology
dc.sourceUniversidad Autónoma de Baja California
dc.subjectMedicine
dc.subjectRefractory (planetary science)
dc.subjectDexamethasone
dc.subjectInternal medicine
dc.subjectOncology
dc.subjectPharmacology
dc.subjectClinical trial
dc.title1308eP Efficacy of isatuximab plus dexamethasone versus non isatuximab-based treatments in refractory multiple myeloma: A systematic review and meta-analysis
dc.typereview

Files

Collections

Artículo Científico Publicado